2B70:F:F-iShares NASDAQ US Biotechnology UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.007

Change

+0.11 (+1.85)%

Market Cap

USD 0.52B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

ETFs Containing 2B70:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.42% 46% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.42% 45% F 49% F
Trailing 12 Months  
Capital Gain 7.31% 46% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.31% 44% F 50% F
Trailing 5 Years  
Capital Gain 44.94% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.94% 64% D 52% F
Average Annual (5 Year Horizon)  
Capital Gain 6.44% 68% D+ 67% D+
Dividend Return 6.44% 67% D+ 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.60% 41% F 72% C
Risk Adjusted Return 44.11% 65% D 71% C-
Market Capitalization 0.52B 62% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.